Reactivating the expression of methylation silenced genes in human cancer.
about
Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines.Silencing of the XAF1 gene by promoter hypermethylation in cancer cells and reactivation to TRAIL-sensitization by IFN-betaGrowth retardation and premature aging phenotypes in mice with disruption of the SNF2-like gene, PASGDNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancerDirect interaction between DNMT1 and G9a coordinates DNA and histone methylation during replicationDNA and the chromosome - varied targets for chemotherapyCombination Approaches with Immune-Checkpoint Blockade in Cancer TherapyMethylation in the core-promoter region of the chondromodulin-I gene determines the cell-specific expression by regulating the binding of transcriptional activator Sp3Mitochondrial pro-apoptotic ARTS protein is lost in the majority of acute lymphoblastic leukemia patientsRegulation of high molecular weight-melanoma associated antigen (HMW-MAA) gene expression by promoter DNA methylation in human melanoma cellsExpression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumorsEpigenetic regulation of thyroid hormone receptor beta in renal cancer.Global demethylation of rat chondrosarcoma cells after treatment with 5-aza-2'-deoxycytidine results in increased tumorigenicityRegulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cellsEpigenetic therapies for chemoresensitization of epithelial ovarian cancer.Epigenetic drugs can stimulate metastasis through enhanced expression of the pro-metastatic Ezrin gene.Differential regulation of the dioxin-induced Cyp1a1 and Cyp1b1 genes in mouse hepatoma and fibroblast cell lines.Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy.X-inactivation normalizes O-GlcNAc transferase levels and generates an O-GlcNAc-depleted Barr body.Prioritizing cancer-related genes with aberrant methylation based on a weighted protein-protein interaction network.Epigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosisGlobal analysis of DNA methylation in early-stage liver fibrosisPromoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.Epigenetic regulation of protein tyrosine phosphatases: potential molecular targets for cancer therapy.A pilot pharmacokinetic study of oral azacitidine.Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients.Augmenting antitumor immune responses with epigenetic modifying agents.Retinoids in cancer therapy and chemoprevention: promise meets resistance.Histone deacetylase inhibitors in clinical development.Epigenetic alterations in head and neck cancer: prevalence, clinical significance, and implications.Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma.Epigenomics of ovarian cancer and its chemoprevention.The depletion of DNA methyltransferase-1 and the epigenetic effects of 5-aza-2'deoxycytidine (decitabine) are differentially regulated by cell cycle progressionChromosomal instability in oral cancer cells.Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: identification of apoptotic genes as targets for demethylationp300 expression repression by hypermethylation associated with tumour invasion and metastasis in oesophageal squamous cell carcinoma.Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence.Mutation and methylation of hMLH1 in gastric carcinomas with microsatellite instabilityDAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis.
P2860
Q21246015-89AC0DBF-BDE3-427D-862C-CA62015C3D73Q21260407-2926B121-7811-463C-B630-E8BF7275D490Q24564106-087CDFC3-907B-4BAA-BF9F-FD2807A041F0Q24615113-1EB90B0B-60FE-4B95-AABD-A1F850915A0CQ24675218-463B4C87-4BB3-40ED-857A-D9AC99C4EDE3Q24792540-8A7E4E95-1D42-4C2C-80AF-6D21AC2D1917Q28066199-8140AAAF-5968-4576-B98B-E10FFD3BBAC0Q28258322-54059677-E422-416B-94A7-420C74C3EB62Q28259737-C243E05D-0C34-492B-97EF-84A6C16C09C5Q28291291-28C69579-599B-498A-AC0B-04097696606BQ28748604-9DFDE8E2-B454-42A9-8A15-9E09ECCF5D33Q31161553-D0A94A60-987F-446E-B959-82D4A96892C0Q33519525-0B608A92-C83D-4254-AA9F-3B975C7FA8B7Q33526045-D3D7AE06-65F3-4123-BFE9-84E4EADB87C3Q33621141-1B28DD5E-5659-4291-9E85-7150F44E2F27Q33698044-25B3C744-2887-4640-AEB3-7DC749F0FC9FQ33729483-E78035B5-A197-49EA-8CA0-D4F5C4BE2859Q33908446-8FD09BFE-A3C9-45F9-B938-56E3395AD43EQ33957165-CC00A869-26BC-49DB-90EB-6E0BE533BFD9Q33997535-E745D31E-9AE4-4193-8B12-FFE7527E85EAQ34045429-813E2949-1374-4551-9CB6-75A4B6A1E3D2Q34087012-0A607A50-A5AE-4EC1-842A-499738074FB1Q34142428-8C75891C-516C-4430-B120-DD19A23C861AQ34247124-6C3C4DD2-0189-49E1-93E5-0237C4B51259Q34528296-D11447AF-DE1C-48B5-A929-DACE3A33065FQ34786094-C1A13A61-693C-4349-ABD2-5FABF7D53884Q35034638-F61C24C1-5055-4D4B-A21D-DAB2D2CEE906Q35048054-1F72F27F-6274-4DAE-AAEC-C649A2C07F4FQ35567239-0B1D5A9B-A9C8-4F2F-B5D1-2B9546976D32Q35609717-EE2304B7-F95B-4480-A26F-2C8143088DF8Q35642648-9D6ECF7B-A651-4461-BC29-325DA8F68D49Q35699313-F9728F3B-A54C-41EF-86F3-05791462F7EDQ35711392-93C1EA75-6300-4BD9-8366-D3979244C23EQ35985465-936AD9B3-38B8-4BCB-925E-3ACB909B13BEQ36019105-9ECBF762-24BA-4F20-85F1-CC6A893FEE67Q36082658-E1B6F3C2-D44B-4E80-BF2D-2173F2380CA0Q36172205-0E27F4BD-59E8-49A3-AFFC-4974292D0EEDQ36173001-A7386FBA-4CDA-4EE7-A18E-277781F0D6DCQ36178601-1A947440-903A-438C-B7E4-1B3810A29634Q36209868-0A2E87C9-94B4-4C2A-8176-30D72F3217DD
P2860
Reactivating the expression of methylation silenced genes in human cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Reactivating the expression of methylation silenced genes in human cancer.
@ast
Reactivating the expression of methylation silenced genes in human cancer.
@en
Reactivating the expression of methylation silenced genes in human cancer.
@nl
type
label
Reactivating the expression of methylation silenced genes in human cancer.
@ast
Reactivating the expression of methylation silenced genes in human cancer.
@en
Reactivating the expression of methylation silenced genes in human cancer.
@nl
prefLabel
Reactivating the expression of methylation silenced genes in human cancer.
@ast
Reactivating the expression of methylation silenced genes in human cancer.
@en
Reactivating the expression of methylation silenced genes in human cancer.
@nl
P2860
P356
P1433
P1476
Reactivating the expression of methylation silenced genes in human cancer.
@en
P2093
Adam R Karpf
David A Jones
P2860
P2888
P304
P356
10.1038/SJ.ONC.1205602
P407
P577
2002-08-01T00:00:00Z
P5875
P6179
1031483503